Stock Earnings

Question 1

Clinuvel Pharmaceuticals Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Clinuvel Pharmaceuticals Ltdの総資産は$271で、純profitは$36です。

Question 2

CLVLYの主要な財務比率は何ですか？

Accepted Answer

Clinuvel Pharmaceuticals Ltdの流動比率は9.03、純利益率は37.89、1株当たり売上高は$1.88です。

Question 3

Clinuvel Pharmaceuticals Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Clinuvel Pharmaceuticals Ltd largest revenue segment is Biopharmaceutical, at a revenue of 88,178,308 in the most earnings release.For geography, Europe & United States is the primary market for Clinuvel Pharmaceuticals Ltd, at a revenue of 81,483,000.

Question 4

Clinuvel Pharmaceuticals Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Clinuvel Pharmaceuticals Ltdの純profitは$36です。

Question 5

Clinuvel Pharmaceuticals Ltdに負債はありますか？

Accepted Answer

yes、Clinuvel Pharmaceuticals Ltdの負債は30です。

Question 6

Clinuvel Pharmaceuticals Ltdの発行済株式数は何株ですか？

Accepted Answer

Clinuvel Pharmaceuticals Ltdの総発行済株式数は50.12株です。

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	95	95	95	82	66	48
Revenue Growth (YoY)	0%	0%	16%	24%	38%	45%
Cost of Revenue	1	1	-1	-7	1	-1
Gross Profit	93	93	96	89	64	50
Selling, General & Admin	38	38	37	39	27	19
Research & Development	7	7	2	1	1	0
Operating Expenses	47	47	41	41	29	20
Other Non Operating Income (Expenses)	0	0	--	--	--	0
Pretax Income	51	51	50	45	34	25
Income Tax Expense	15	15	15	14	13	0
Net Income	36	36	35	30	20	24
Net Income Growth	3%	3%	17%	50%	-17%	60%
Shares Outstanding (Diluted)	50.49	50.37	51.02	51.81	51.77	51.13
Shares Change (YoY)	0%	-1%	-2%	0%	1%	1%
EPS (Diluted)	0.71	0.71	0.69	0.59	0.4	0.48
EPS Growth	2%	3%	18%	46%	-17%	62%
Free Cash Flow	40	40	31	35	39	18
Free Cash Flow Per Share	0.79	0.79	0.6	0.67	0.75	0.35
Gross Margin	97.89%	97.89%	101.05%	108.53%	96.96%	104.16%
Operating Margin	47.36%	47.36%	57.89%	58.53%	53.03%	60.41%
Profit Margin	37.89%	37.89%	36.84%	36.58%	30.3%	50%
Free Cash Flow Margin	42.1%	42.1%	32.63%	42.68%	59.09%	37.5%
EBITDA	46	46	56	48	35	29
EBITDA Margin	48.42%	48.42%	58.94%	58.53%	53.03%	60.41%
D&A For EBITDA	1	1	1	0	0	0
EBIT	45	45	55	48	35	29
EBIT Margin	47.36%	47.36%	57.89%	58.53%	53.03%	60.41%
Effective Tax Rate	29.41%	29.41%	30%	31.11%	38.23%	0%

Clinuvel Pharmaceuticals Ltd (CLVLY) Price

CLVLY Stock Price Chart

CLVLY Income

Follow-Up Questions